CryoPort (CryoPort) Float Percentage Of Total Shares Outstanding : 82.73% (As of Apr. 27, 2024)

View and export this data going back to 1993. Start your Free Trial

What is CryoPort Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, CryoPort's float shares is 40.67 Mil. CryoPort's total shares outstanding is 49.16 Mil. CryoPort's float percentage of total shares outstanding is 82.73%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, CryoPort's Insider Ownership is 3.02%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, CryoPort's Institutional Ownership is 74.46%.

CryoPort Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

CryoPort's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	40.67	/	49.16
	=	82.73%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CryoPort (CryoPort) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » CryoPort Inc (NAS:CYRX) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

CKX:Germany

Address

112 Westwood Place, Suite 350, Brentwood, TN, USA, 37027

Website

https://www.cryoport.com

CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

Executives

Robert J Hariri	director	341 MENDHAM ROAD, BERNARDSVILLE NJ 07924
Jerrell Shelton	director, officer: President, CEO	C/O NETRATINGS INC, 120 WEST 45TH STREET 35TH FLOOR, NEW YORK NY 10036
Richard J Berman	director	305 COLLEGE ROAD EAST, PRINCETON NJ 08540
Robert Stefanovich	officer: Chief Financial Officer
Mark W Sawicki	officer: Chief Scientific Officer	3303 LAKEPOINTE DRIVE, BELMONT NC 28012
Blackstone Holdings Ii L.p.	10 percent owner	C/O BLACKSTONE INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Tactical Opportunities Fund - Fd L.p.	10 percent owner	C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Daniel M Hancock	director	7729 S. BELMONT, INDIANAPOLIS IN 46217
Edward J Zecchini	director	20382 BARENTS SEA CIRCLE, LAKE FOREST CA 92630
Linda Baddour	director	PRA INTERNATIONAL, 12120 SUNSET HILLS ROAD, SUITE 600, RESTON VA 20190
Ramkumar Mandalam	director	4344 PICKEREL DRIVE, UNION CITY CA 94587
Ram M. Jagannath	director	C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Stephen A Schwarzman	10 percent owner	C/O BLACKSTONE INC., 345 PARK AVE, NEW YORK NY 10154
Blackstone Tactical Opportunities Associates Iii - Nq L.p.	10 percent owner	C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Freeze Parent L.p.	10 percent owner	C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154